Genialis

Genialis develops end-to-end bioinformatics software solutions combining biomedical data management, customizable data analysis pipelines, and interactive visualizations. The platform provides a complete data ecosystem for sequencing data management, analysis, visualization, and dissemination. Founded in 2015 and headquartered in Boston, United States, Genialis has raised $16M in Series A funding from investors including Redalpine, First Star Ventures, Debiopharm, EIC Fund, and ScaleX. The company offers cloud-based and on-premise software that automates data management and analysis tasks for genomics research, serving pharmaceutical companies, academic institutions, and clinical research organizations with tools for RNA-seq analysis, biomarker discovery, and translational research. The company employs 30 people and its platform accelerates the translation of genomic discoveries into clinical applications by streamlining complex bioinformatics workflows.